Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (481-490 of 524) with videos related to

Pageof 53
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung CancerArielle Elkrief, Meagan Montesion, Smruthy Sivakumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Cancer Cell|March 31, 2023
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockadeJoy A Pai, Matthew D Hellmann, Jennifer L Sauter, et al.
The Journal of Clinical Investigation|June 14, 2016
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancerKipp Weiskopf, Nadine S Jahchan, Peter J Schnorr, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growthAli Rashidfarrokhi, Ray Pillai, Yuan Hao, et al.
Frontiers in Oncology|October 5, 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapyEmily S Lebow, Narek Shaverdian, Jordan E Eichholz, et al.
Cancer Discovery|June 22, 2021
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine TransformationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Pageof 53

Showing results (481-490 of 524) with videos related to

Sort By:
Pageof 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung CancerArielle Elkrief, Meagan Montesion, Smruthy Sivakumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Cancer Cell|March 31, 2023
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockadeJoy A Pai, Matthew D Hellmann, Jennifer L Sauter, et al.
The Journal of Clinical Investigation|June 14, 2016
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancerKipp Weiskopf, Nadine S Jahchan, Peter J Schnorr, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growthAli Rashidfarrokhi, Ray Pillai, Yuan Hao, et al.
Frontiers in Oncology|October 5, 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapyEmily S Lebow, Narek Shaverdian, Jordan E Eichholz, et al.
Cancer Discovery|June 22, 2021
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine TransformationAlvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A Zhan, et al.
Pageof 53